Keppra and Alinia drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Keppra (levetiracetam) and Alinia (nitazoxanide). Common drug interactions include osteopenia among females and cognitive disorder among males.
The phase IV clinical study analyzes what interactions people have when they take Keppra and Alinia. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Keppra?
Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.
What is Alinia?
Alinia has active ingredients of nitazoxanide. eHealthMe is studying from 560 Alinia users. Check the latest studies of Alinia.
12 people who take Keppra and Alinia together, and have interactions are studied.

What are the common drug interactions of Keppra and Alinia, by gender? *:
female:
- Osteopenia (a condition where bone mineral density is lower than normal)
- Osteoporosis (bones weak and more likely to break)
- Wrist fracture
male:
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Tick-borne fever (fever due to tick bite infection)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Circadian rhythm sleep disorder (family of sleep disorders affecting, among other things, the timing of sleep)
- Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
- Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Hypersomnia (excessive daytime sleepiness (eds))
- Asthenia (weakness)
- Babesiosis (malaria-like parasitic disease caused by infection with babesia)
What are the existing conditions these people have? *
- Drowsiness: 8 people, 66.67%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 16.67%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 16.67%
- Apnea (temporary absence or cessation of breathing): 2 people, 16.67%
- Urinary Tract Infection: 1 person, 8.33%
- Tick-Borne Fever (fever due to tick bite infection): 1 person, 8.33%
- Spinal Column Injury (spinal cord bone injury): 1 person, 8.33%
- Sinusitis (inflammation of sinus): 1 person, 8.33%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 8.33%
- Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Keppra and Alinia?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Keppra and Alinia:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Alinia:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Keppra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Alinia and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on levetiracetam and nitazoxanide (the active ingredients of Keppra and Alinia, respectively), and Keppra and Alinia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fish Oil and Primary Hypogonadism for Men aged 50-59 - 16 seconds ago
- Children'S Allegra Hives vs. Zyrtec, side effect and effectiveness comparison - 18 seconds ago
- Drug interactions of Doxycycline Hyclate and Xyzal - 26 seconds ago
- How effective is Atenolol for Angina? - 30 seconds ago
- Drug interactions of Pitavastatin Calcium and Enalapril Maleate - 39 seconds ago
- Necrotising Fasciitis and drugs of ingredients of valproic acid - 47 seconds ago
- Drug interactions of Valacyclovir Hydrochloride and Nucala - a minute ago
- Drug interactions of Loraz and Monistat - a minute ago
- Drug interactions of Salvia Miltiorrhiza and Acyclovir - a minute ago
- Stribild and Spinal Osteoarthritis for Men aged 50-59 - a minute ago